{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:03:59Z","timestamp":1791198239326,"version":"4.1.0"},"reference-count":141,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2010,11,14]],"date-time":"2010-11-14T00:00:00Z","timestamp":1289692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p><jats:bold>Abstract.\u2002<\/jats:bold> Mackenzie IS, Coughtrie MWH, MacDonald TM, Wei L. (Medicines Monitoring Unit (MEMO); and Centre for Oncology &amp; Molecular Medicine, Division of Medical Sciences, University of Dundee, Ninewells Hospital &amp; Medical School; Dundee, UK). Antiplatelet drug interactions (Review\u2010Symposium). <jats:italic>J Intern Med<\/jats:italic> 2010; <jats:bold>268<\/jats:bold>: 516\u2013529.<\/jats:p><jats:p>Both laboratory studies in healthy volunteers and clinical studies have suggested adverse interactions between antiplatelet drugs and other commonly used medications. Interactions described include those between aspirin and ibuprofen, aspirin and other nonsteroidal anti\u2010inflammatory drugs (NSAIDs), and the thienopyridine, clopidogrel, and drugs inhibiting CYP2C19, notably the proton pump inhibitors (PPI) omeprazole and esomeprazole. Other interactions between thienopyridines and CYP3A4\/5 have also been reported for statins and calcium channel blockers. The ibuprofen\/aspirin interaction is thought to be caused by ibuprofen blocking the access of aspirin to platelet cyclo\u2010oxygenase. The thienopyridine interactions are caused by inhibition of microsomal enzymes that metabolize these pro\u2010drugs to their active metabolites. We review the evidence for these interactions, assess their clinical importance and suggest strategies of how to deal with them in clinical practice. We conclude that ibuprofen is likely to interact with aspirin and reduce its anti\u2010platelet action particularly in those patients who take ibuprofen chronically. This interaction is of greater relevance to those patients at high cardiovascular risk. A sensible strategy is to advise users of aspirin to avoid chronic ibuprofen or to ingest aspirin at least 2\u2003h prior to ibuprofen. Clearly the use of NSAIDs that do not interact in this way is preferred. For the clopidogrel CYP2C19 and CYP3A4\/5 interactions, there is good evidence that these interactions occur. However, there is less good evidence to support the clinical importance of these interactions. Again, a reasonable strategy is to avoid the chronic use of drugs that inhibit CYP2C19, notably PPIs, in subjects taking clopidogrel and use high dose H2 antagonists instead. Finally, anti\u2010platelet agents probably interact with other drugs that affect platelet function such as selective serotonin reuptake inhibitors, and clinicians should probably judge patients taking such combination therapies as at high risk for bleeding.<\/jats:p>","DOI":"10.1111\/j.1365-2796.2010.02299.x","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T01:46:22Z","timestamp":1289785582000},"page":"516-529","source":"Crossref","is-referenced-by-count":44,"title":["Antiplatelet drug interactions"],"prefix":"10.1111","volume":"268","author":[{"given":"I. S.","family":"Mackenzie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W. H.","family":"Coughtrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. M.","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,11,14]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60503-1"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.19.2197"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.85.3.265"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-2-200201150-00016"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp012672"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-6-200903170-00009"},{"key":"e_1_2_14_8_2","first-page":"917","article-title":"Antiplatelet therapy and atherosclerotic events. Risks and patients\u2019 values need to be included in decision about aspirin for prevention of coronary heart disease","volume":"324","author":"Pignone M","year":"2002","journal-title":"BMJ"},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.623"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.221"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a1840"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.623"},{"key":"e_1_2_14_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050613"},{"key":"e_1_2_14_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7329.71"},{"key":"e_1_2_14_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4531"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1805"},{"key":"e_1_2_14_17_2","first-page":"110","article-title":"The mechanism of action of aspirin","volume":"15","author":"Vane JR","year":"2003","journal-title":"Thromb Res"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.8.3073"},{"key":"e_1_2_14_19_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000013777.21160.07"},{"key":"e_1_2_14_20_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000015422.86569.52"},{"key":"e_1_2_14_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)03014-0"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39430.529549.BE"},{"key":"e_1_2_14_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.10.021"},{"key":"e_1_2_14_24_2","first-page":"233","article-title":"Thrombosis prevention trial: randomised trial of low\u2010intensity oral anticoagulation with warfarin and low\u2010dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council\u2019s General Practice Research Framework","volume":"35","year":"1998","journal-title":"Lancet"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-6175.2004.02850.x"},{"key":"e_1_2_14_26_2","unstructured":"http:\/\/www.isdscotland.org\/isd\/information\u2010and\u2010statistics.jsp?pContentID=2229&p_applic=CCC&p_service=Content.show& [accessed on 26 October 2010]."},{"key":"e_1_2_14_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.01.049"},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(01)00461-9"},{"key":"e_1_2_14_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12266"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38456.676806.8F"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67462-4"},{"key":"e_1_2_14_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01979.x"},{"key":"e_1_2_14_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07370-1"},{"key":"e_1_2_14_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.9.978"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.10.1099"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.10.1111"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000132491.96623.04"},{"key":"e_1_2_14_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200007000-00004"},{"key":"e_1_2_14_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.4.481"},{"key":"e_1_2_14_40_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000127578.21885.3E"},{"key":"e_1_2_14_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17864-7"},{"key":"e_1_2_14_42_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/14.7.951"},{"key":"e_1_2_14_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019501-199809040-00007"},{"key":"e_1_2_14_44_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.13.jrv60011"},{"key":"e_1_2_14_45_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.332.7553.1302"},{"key":"e_1_2_14_46_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.109.861104"},{"key":"e_1_2_14_47_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021735"},{"key":"e_1_2_14_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2006.pto_371.x"},{"key":"e_1_2_14_49_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.251543298"},{"key":"e_1_2_14_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.3.4.383"},{"key":"e_1_2_14_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/0090-6980(82)90123-X"},{"key":"e_1_2_14_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.045"},{"key":"e_1_2_14_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2007.11.054"},{"key":"e_1_2_14_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa003199"},{"key":"e_1_2_14_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00243.x"},{"key":"e_1_2_14_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12509-3"},{"key":"e_1_2_14_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.08.064"},{"key":"e_1_2_14_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.01.001"},{"key":"e_1_2_14_59_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.307.6908.846"},{"key":"e_1_2_14_60_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.25.4.503.61021"},{"key":"e_1_2_14_61_2","first-page":"1589","article-title":"Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction","volume":"32","author":"Hudson M","year":"2005","journal-title":"J Rheumatol"},{"key":"e_1_2_14_62_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7427.1322"},{"key":"e_1_2_14_63_2","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2002.121270"},{"key":"e_1_2_14_64_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7427.1298"},{"key":"e_1_2_14_65_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000087593.07533.9B"},{"key":"e_1_2_14_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16894-3"},{"key":"e_1_2_14_67_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-123-4-199508150-00001"},{"key":"e_1_2_14_68_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.10.1247"},{"key":"e_1_2_14_69_2","first-page":"522","article-title":"CLASS clarification: reaffirms the medical importance of the analyses and results","volume":"327","author":"Geis GS","year":"2003","journal-title":"BMJ"},{"key":"e_1_2_14_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16893-1"},{"key":"e_1_2_14_71_2","unstructured":"http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm125222.htm[accessed 18 June 2010]."},{"key":"e_1_2_14_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61909-6"},{"key":"e_1_2_14_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60673-3"},{"key":"e_1_2_14_74_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.181424"},{"key":"e_1_2_14_75_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000124715.27937.78"},{"key":"e_1_2_14_76_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.895342"},{"key":"e_1_2_14_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.09.011"},{"key":"e_1_2_14_78_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61751-7"},{"key":"e_1_2_14_79_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-1-201001050-00179"},{"key":"e_1_2_14_80_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.191087"},{"key":"e_1_2_14_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61246-0"},{"key":"e_1_2_14_82_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103293441304"},{"key":"e_1_2_14_83_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012877"},{"key":"e_1_2_14_84_2","unstructured":"http:\/\/www.isdscotland.org\/isd\/information\u2010and\u2010statistics.jsp?pContentID=2229&p_applic=CCC&p_service=Content.show& [accessed 26 October 2010]."},{"key":"e_1_2_14_85_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2001.4816"},{"key":"e_1_2_14_86_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029132"},{"key":"e_1_2_14_87_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060664"},{"key":"e_1_2_14_88_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.12.1483"},{"key":"e_1_2_14_89_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241120-00002"},{"key":"e_1_2_14_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp041"},{"key":"e_1_2_14_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61845-0"},{"key":"e_1_2_14_92_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.1232"},{"key":"e_1_2_14_93_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808227"},{"key":"e_1_2_14_94_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0809171"},{"key":"e_1_2_14_95_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.885194"},{"key":"e_1_2_14_96_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.02162.x"},{"key":"e_1_2_14_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.06.064"},{"key":"e_1_2_14_98_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-12-0808"},{"key":"e_1_2_14_99_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.05.050"},{"key":"e_1_2_14_100_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.34"},{"key":"e_1_2_14_101_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2009.261"},{"key":"e_1_2_14_102_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.082001"},{"key":"e_1_2_14_103_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-0960-8"},{"key":"e_1_2_14_104_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-152-6-201003160-00003"},{"key":"e_1_2_14_105_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.873497"},{"key":"e_1_2_14_106_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2010.04247.x"},{"key":"e_1_2_14_107_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007964"},{"key":"e_1_2_14_108_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-153-6-201009210-00005"},{"key":"e_1_2_14_109_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e3181ee08ed"},{"key":"e_1_2_14_110_2","unstructured":"SouthworthMR.FDA Letter of Approval: November 12 2009 NDA 20\u2010839\/S\u2010044. U.S. Food and Drug Administration. Available at:http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2009\/020839s044ltr.pdf[accessed 2 July 2010]."},{"key":"e_1_2_14_111_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000047060.60595.CC"},{"key":"e_1_2_14_112_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.18.2051"},{"key":"e_1_2_14_113_2","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-08-0503"},{"key":"e_1_2_14_114_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2009.02119.x"},{"key":"e_1_2_14_115_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050706"},{"key":"e_1_2_14_116_2","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2009.171488"},{"key":"e_1_2_14_117_2","doi-asserted-by":"publisher","DOI":"10.1021\/tx1001332"},{"key":"e_1_2_14_118_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009343005"},{"key":"e_1_2_14_119_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.110.032086"},{"key":"e_1_2_14_120_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.105.007989"},{"key":"e_1_2_14_121_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.028498"},{"key":"e_1_2_14_122_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.740324"},{"key":"e_1_2_14_123_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.851949"},{"key":"e_1_2_14_124_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehp159"},{"key":"e_1_2_14_125_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"e_1_2_14_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60441-4"},{"key":"e_1_2_14_127_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.912550"},{"key":"e_1_2_14_128_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.919456"},{"key":"e_1_2_14_129_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2009.10.010"},{"key":"e_1_2_14_130_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.1.59"},{"key":"e_1_2_14_131_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2006.01720.x"},{"key":"e_1_2_14_132_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1388-9842(03)00005-9"},{"key":"e_1_2_14_133_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7217.1106"},{"key":"e_1_2_14_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.08.019"},{"key":"e_1_2_14_135_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.26.9.1307"},{"key":"e_1_2_14_136_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03154.x"},{"key":"e_1_2_14_137_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200831020-00005"},{"key":"e_1_2_14_138_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38883.479549.2F"},{"key":"e_1_2_14_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90276-7"},{"key":"e_1_2_14_140_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.9.1145"},{"key":"e_1_2_14_141_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61562-2"},{"key":"e_1_2_14_142_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029132"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2796.2010.02299.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2796.2010.02299.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T06:43:37Z","timestamp":1698907417000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2796.2010.02299.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,14]]},"references-count":141,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1111\/j.1365-2796.2010.02299.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2796.2010.02299.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,14]]}}}